scholarly journals Drug allergy passport and other documentation for patients with drug hypersensitivity - An ENDA/EAACI Drug Allergy Interest Group Position Paper

Allergy ◽  
2016 ◽  
Vol 71 (11) ◽  
pp. 1533-1539 ◽  
Author(s):  
K. Brockow ◽  
W. Aberer ◽  
M. Atanaskovic-Markovic ◽  
S. Bavbek ◽  
A. Bircher ◽  
...  
Keyword(s):  
Interest Group ◽  
Drug Allergy ◽  
Drug Hypersensitivity ◽  
Position Paper ◽  
Group Position

In vitrotests for drug hypersensitivity reactions: an ENDA/EAACI Drug Allergy Interest Group position paper

Allergy ◽  
2016 ◽  
Vol 71 (8) ◽  
pp. 1103-1134 ◽  
Author(s):  
C. Mayorga ◽  
G. Celik ◽  
P. Rouzaire ◽  
P. Whitaker ◽  
P. Bonadonna ◽  
...  
Keyword(s):  
Interest Group ◽  
Drug Allergy ◽  
Drug Hypersensitivity ◽  
Position Paper ◽  
Hypersensitivity Reactions ◽  
Group Position ◽  
Drug Hypersensitivity Reactions

scholarly journals Skin test concentrations for systemically administered drugs - an ENDA/EAACI Drug Allergy Interest Group position paper

Allergy ◽  
2013 ◽  
Vol 68 (6) ◽  
pp. 702-712 ◽  
Author(s):  
K. Brockow ◽  
L. H. Garvey ◽  
W. Aberer ◽  
M. Atanaskovic-Markovic ◽  
A. Barbaud ◽  
...  
Keyword(s):  
Skin Test ◽  
Interest Group ◽  
Drug Allergy ◽  
Position Paper ◽  
Group Position

scholarly journals Desensitization in delayed drug hypersensitivity reactions - an EAACI position paper of the Drug Allergy Interest Group

Allergy ◽  
2013 ◽  
Vol 68 (7) ◽  
pp. 844-852 ◽  
Author(s):  
K. Scherer ◽  
K. Brockow ◽  
W. Aberer ◽  
J. H. C. Gooi ◽  
P. Demoly ◽  
...  
Keyword(s):  
Interest Group ◽  
Drug Allergy ◽  
Drug Hypersensitivity ◽  
Position Paper ◽  
Hypersensitivity Reactions ◽  
Drug Hypersensitivity Reactions

scholarly journals Sterility Special Interest Group position paper on ART treatments and COVID 19 pandemic

2020 ◽  
Vol 32 (03) ◽  
pp. 154
Author(s):  
C. Alviggi ◽  
A. Borini ◽  
M. Costa ◽  
G. D'Amato ◽  
L. Gianaroli ◽  
...  
Keyword(s):  
Interest Group ◽  
Special Interest ◽  
Position Paper ◽  
Special Interest Group ◽  
Group Position

scholarly journals Drug hypersensitivity in children: report from the pediatric task force of the EAACI Drug Allergy Interest Group

Allergy ◽  
2015 ◽  
Vol 71 (2) ◽  
pp. 149-161 ◽  
Author(s):  
E. R. Gomes ◽  
K. Brockow ◽  
S. Kuyucu ◽  
F. Saretta ◽  
F. Mori ◽  
...  
Keyword(s):  
Interest Group ◽  
Drug Allergy ◽  
Task Force ◽  
Drug Hypersensitivity

scholarly journals Hypersensitivity Reactions To Chemotherapy: an EAACI Position Paper

2021 ◽  
Author(s):  
Mauro Pagani ◽  
Sevim Bavbek ◽  
Emilio Alvarez-Cuesta ◽  
patrizia Bonadonna ◽  
Josefina Cernadas ◽  
...  
Keyword(s):  
Drug Allergy ◽  
Task Force ◽  
Drug Hypersensitivity ◽  
The United States ◽  
Position Paper ◽  
Skin Tests ◽  
In Vitro Tests ◽  
Hypersensitivity Reactions ◽  
Chemotherapeutic Drugs ◽  
Cancer Disease

Chemotherapeutic drugs have been widely used in the treatment of cancer disease for about 70 years and, even with the development of new therapies, they are still prescribed by oncologists, alone or in combination with other antineoplastic agents. All chemotherapies are able to provoke hypersensitivity reactions, even with different incidences, depending on the different class of these drugs, and these reactions are the third leading cause of fatal drug-induced anaphylaxis in the United States. In Europe deaths related to chemotherapy have also been reported. In particular, most reactions are provoked by platinum compounds, taxanes, epipodophyllotoxins and asparaginase. However, currently there are different points of view about the best procedures for the diagnosis, treatment and prevention of these reactions. Thus, the European Network on Drug Allergy and Drug Allergy Interest Group of the European Academy of Allergy and Clinical Immunology organized a task force to provide data and recommendations regarding the allergological work up in this field of drug hypersensitivity reactions. The aims of this position paper were to provide consensus on the investigation of HSRs to chemotherapeutic drugs and to give practical suggestions for clinicians that treat these patients, such as oncologists, allergologists and internists. Key sections cover: risk factors, pathogenesis, symptoms, role of skin tests, in vitro tests, indications and contraindications of drug provocation tests and desensitization of neoplastic patients with allergic reactions to chemotherapeutic drugs. Statements, recommendations and unmet needs were discussed and proposed at the end of each section.

Voice Pedagogy for the 21st Century: The Summation of Two Summits

2021 ◽  
Vol 78 (1) ◽  
pp. 11-28
Author(s):  
Amelia Rollings Bigler ◽  
Katherine Osborne ◽  
Chadley Ballantyne ◽  
Brian Horne ◽  
Kimberly James ◽  
...  
Keyword(s):  
Interest Group ◽  
21St Century ◽  
Teaching Profession ◽  
Position Paper ◽  
Voice Pedagogy ◽  
Knowledge And Skills ◽  
Education Experience ◽  
Voice Teaching ◽  
The Voice ◽  
The Ideal

The Voice Pedagogy Interest Group held its second summit in May 2018 to establish and recommend a logical curriculum that prepares and trains those entering the voice teaching profession with knowledge and skills needed to succeed. This position paper codifies the expanding competencies necessary for a 21st century teacher of singing and presents a vision of the ideal singing teacher’s education, experience, knowledge, and skill.

scholarly journals Extracellular vesicles in diagnostics and therapy of the ischaemic heart: Position Paper from the Working Group on Cellular Biology of the Heart of the European Society of Cardiology

2017 ◽  
Vol 114 (1) ◽  
pp. 19-34 ◽  
Author(s):  
Joost Petrus Gerardus Sluijter ◽  
Sean Michael Davidson ◽  
Chantal M Boulanger ◽  
Edit Iren Buzás ◽  
Dominique Paschalis Victor de Kleijn ◽  
...  
Keyword(s):  
Extracellular Vesicles ◽  
Working Group ◽  
Position Paper ◽  
Paracrine Effects ◽  
Group Position ◽  
Wide Range ◽  
Potential Alternative ◽  
Number Of Publications ◽  
European Society Of Cardiology ◽  
Regenerative Therapies

AbstractExtracellular vesicles (EVs)—particularly exosomes and microvesicles (MVs)—are attracting considerable interest in the cardiovascular field as the wide range of their functions is recognized. These capabilities include transporting regulatory molecules including different RNA species, lipids, and proteins through the extracellular space including blood and delivering these cargos to recipient cells to modify cellular activity. EVs powerfully stimulate angiogenesis, and can protect the heart against myocardial infarction. They also appear to mediate some of the paracrine effects of cells, and have therefore been proposed as a potential alternative to cell-based regenerative therapies. Moreover, EVs of different sources may be useful biomarkers of cardiovascular disease identities. However, the methods used for the detection and isolation of EVs have several limitations and vary widely between studies, leading to uncertainties regarding the exact population of EVs studied and how to interpret the data. The number of publications in the exosome and MV field has been increasing exponentially in recent years and, therefore, in this ESC Working Group Position Paper, the overall objective is to provide a set of recommendations for the analysis and translational application of EVs focussing on the diagnosis and therapy of the ischaemic heart. This should help to ensure that the data from emerging studies are robust and repeatable, and optimize the pathway towards the diagnostic and therapeutic use of EVs in clinical studies for patient benefit.

Sign in / Sign up

Export Citation Format

Share Document